Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methane | HCID 297 | — |
| Reactant | Caprolactam | HCID 7768 | — |
| Reactant | 1-Benzoyl-3-chloroazepan-2-one | HCID 282191 | — |
| Solvent | 1,2-Dichlorobenzene | HCID 7239 | — |
| Product | Caprolactam | HCID 7768 | — |
| Product | 3-Chloroazepan-2-one | HCID 351602 | — |
Reaction Steps
The ODCB solution of N-benzoyl-α-chloro-ε-caprolactam is passed through a charcoal bed to remove tars as impurities. It is then passed into another reaction vessel where 9718 parts (86 mols) of ε-caprolactam are added. The transamidation is conducted by heating and stirring the ODCB solution at 140° C. for 2 hours. The solution is then cooled to 5° C. for 1 hour whereupon 21,000 parts (82 mols) N-benzoyl-α-chloro-ε-caprolactam precipitates out of the solution. The N-benzoyl-α-chloro-ε-caprolactam is filtered off and saved for recycle. The ODCB solution is then extracted with 250,000 parts 8 weight percent aqueous hydrochloric acid to remove α-chloro-ε-caprolactam and residual ε-caprolactam. The aqueous hydrochloric acid is then extracted countercurrently with 250,000 parts chloroform, and the chloroform extract evaporated to yield 10,915 parts (74 mols) of α-chloro-ε-caprolactam and 1356 parts (12 mols) of ε-caprolactam. The ε-caprolactam is separated from the α-chloro-ε-caprolactam by fractional distillation under vacuum and recycled to the transamidation step.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04044001 |
|---|
| Source dataset | uspto-grants-1977_08 |
|---|
| ORD ID | ord-b7abaae0f6d944b8950128c24fe63ab4 |
|---|
| Source note | uspto-grants-1977_08 |
|---|